pfs25m-epa/alhydrogel
Vaccineexperimental
Clinical trial activity
3 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
3
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Aug 1, 2011 (NCT01434381)
Timeline
2010s
- Jan 1, 2011
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Plasmodium falciparumImmunity, active
Plasmodium falciparum immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- pfs25-epa/alhydrogel
- pfs25m-epa/alhydrogel
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02334462 | Phase 1 | Dec 10, 2014 | Charles Mérieux Center for Infectious Disease, Mali, National Institute of Allergy and Infectious Diseases (NIAID) |
| NCT01867463 | Phase 1 | Mar 27, 2013 | Malaria Research and Training Center, Bamako, Mali, National Institute of Allergy and Infectious Diseases (NIAID) |
| NCT01434381 | Phase 1 | Aug 1, 2011 | National Institute of Allergy and Infectious Diseases (NIAID) |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| National Institute of Allergy and Infectious Diseases (NIAID) | Government | 3 | 3 | 1 | 2011 |
| Charles Mérieux Center for Infectious Disease, Mali | Academic/Hospital | 1 | 0 | 1 | 2014 |
| Malaria Research and Training Center, Bamako, Mali | Academic/Hospital | 1 | 0 | 1 | 2013 |
3 organizations
Page 1 / 1